257 related articles for article (PubMed ID: 25944812)
1. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
2. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
3. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
4. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
5. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
6. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
[TBL] [Abstract][Full Text] [Related]
7. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.
Nardi-Agmon I; Abud-Hawa M; Liran O; Gai-Mor N; Ilouze M; Onn A; Bar J; Shlomi D; Haick H; Peled N
J Thorac Oncol; 2016 Jun; 11(6):827-37. PubMed ID: 26968885
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive breath analysis of pulmonary nodules.
Peled N; Hakim M; Bunn PA; Miller YE; Kennedy TC; Mattei J; Mitchell JD; Hirsch FR; Haick H
J Thorac Oncol; 2012 Oct; 7(10):1528-33. PubMed ID: 22929969
[TBL] [Abstract][Full Text] [Related]
9. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
10. Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers.
Capone S; Tufariello M; Forleo A; Longo V; Giampetruzzi L; Radogna AV; Casino F; Siciliano P
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29131420
[TBL] [Abstract][Full Text] [Related]
11. Searching for selected VOCs in human breath samples as potential markers of lung cancer.
Rudnicka J; Kowalkowski T; Buszewski B
Lung Cancer; 2019 Sep; 135():123-129. PubMed ID: 31446984
[TBL] [Abstract][Full Text] [Related]
12. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy control by breath profile with application of SPME-GC/MS method.
Ulanowska A; Trawińska E; Sawrycki P; Buszewski B
J Sep Sci; 2012 Nov; 35(21):2908-13. PubMed ID: 23001965
[TBL] [Abstract][Full Text] [Related]
14. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
15. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS.
Poli D; Goldoni M; Corradi M; Acampa O; Carbognani P; Internullo E; Casalini A; Mutti A
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2643-51. PubMed ID: 20149763
[TBL] [Abstract][Full Text] [Related]
16. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
[TBL] [Abstract][Full Text] [Related]
17. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
18. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
19. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
[TBL] [Abstract][Full Text] [Related]
20. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
